Gestational diabetes mellitus (GDM), which is the most common metabolic disturbance during gestation, is defined as diabetes first identified during the second or third trimester of gestation that is not preexisting overt diabetes before pregnancy. The global incidence of GDM during pregnancy is increasing continuously. GDM is a significant modifiable risk factor for adverse pregnancy outcomes. It is also linked to adverse long-term health issues for both mothers and their children. A global consensus on the diagnosis of GDM has yet to be reached. Numerous theories have been posited to understand the origins of insulin resistance. Yet, the precise mechanisms driving insulin resistance in various pathologies remain elusive. Further investigation into these mechanisms is essential to identify viable targets for effective insulin resistance treatments. Despite extensive knowledge and recent advancements regarding GDM, there remain significant gaps in applying molecular insights to develop effective treatment modalities for this condition. More research is necessary to develop successful prevention strategies for GDM, establish clear definitions for GDM in every stage of pregnancy, identify additional biomarkers for predicting GDM and pregnancy complications, and understand the long-term metabolic risks and optimal management for both mother and infant after birth.
This Article Collection seeks to compile articles focusing on advancements in understanding and predicting GDM. It aims to propose optimal management strategies and offer insights into recent research on maternal and neonatal complications associated with this complication. Contributions exploring novel diagnostic methods and fresh perspectives on this significant pregnancy complication are also encouraged. Topics covered will include but are not limited to:
All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this Collection will not be handling the manuscripts.
Please review the journal scope and author submission instructions prior to submitting a manuscript.
The deadline for submitting manuscripts is January 31st, 2025.
Please contact Menghan Li at [email protected] with any queries and discount codes regarding this Article Collection.
Please be sure to select the appropriate Article Collection from the drop-down menu in the submission system.
https://think.taylorandfrancis.com/article_collections/latest-developments-in-gestational-diabetes-mellitus/